BPTS / Why Is Biophytis (BPTS) Stock Up 42% Today?

Biophytis (BPTS) gains on signing a partnership with Skyepharma, for the production of regulatory batches of its lead candidate, Sarconeos (BIO101). more_horizontal

Shares of Biophytis (NASDAQ:BPTS, EPA:ALBPS), a clinical-stage biotechnology firm, soared 41% in premarket trading on Nasdaq following the announcemen more_horizontal

Biophytis (NASDAQ: BPTS ) stock is rising higher on Monday after the company announced a Sarconeos production agreement. According to a press release more_horizontal

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / September 4, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis" or the "Co more_horizontal

Biophytis (NASDAQ: BPTS ) stock is soaring higher on Tuesday as investors react to a positive opinion for its upcoming Phase 3 clinical trial. The big more_horizontal

The iShares Russell 2000 ETF NYSE: IWM has experienced impressive upward momentum in recent weeks. The result of the continued strength in the IWM has more_horizontal

Biophytis (NASDAQ: BPTS ) stock is rocketing higher on Tuesday following after announcing a production partnership with SEQENS. According to a press r more_horizontal

Biophytis (NASDAQ: BPTS ) stock is seeing wild movement on Thursday morning but it's nothing for traders to be worried about. Instead, the company has more_horizontal